Clinical Trial Update: TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating TCR-T cell immunotherapy for non-small cell lung cancer and other solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TCR-T cell immunotherapy

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Nonsmall Cell Lung Cancer, Solid Tumor, Adult | Phase 1 | Status: RECRUITING